Cargando…

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models

Metastasis is the leading cause of mortality in cancer patients. L-type amino acid transporter 1 (LAT1, SLC7A5) is a Na(+)-independent neutral amino acid transporter highly expressed in various cancers to support their growth. Although high LAT1 expression is closely associated with cancer metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Zitong, Kaneda-Nakashima, Kazuko, Ohgaki, Ryuichi, Xu, Minhui, Okanishi, Hiroki, Endou, Hitoshi, Nagamori, Shushi, Kanai, Yoshikatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457391/ https://www.ncbi.nlm.nih.gov/pubmed/37626086 http://dx.doi.org/10.1038/s41598-023-41096-3

Ejemplares similares

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022)

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)

Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 1
por: Okanishi, Hiroki, et al.
Publicado: (2022)

Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With α-Alkyl Moieties
por: Khunweeraphong, Narakorn, et al.
Publicado: (2012)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging
por: Wei, Ling, et al.
Publicado: (2016)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

NRFL-1, the C. elegans NHERF Orthologue, Interacts with Amino Acid Transporter 6 (AAT-6) for Age-Dependent Maintenance of AAT-6 on the Membrane
por: Hagiwara, Kohei, et al.
Publicado: (2012)

Ratiometric fluorescence imaging of cell surface pH by poly(ethylene glycol)-phospholipid conjugated with fluorescein isothiocyanate
por: Ohgaki, Ryuichi, et al.
Publicado: (2017)

α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1
por: Kaneda‐Nakashima, Kazuko, et al.
Publicado: (2021)

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
por: Cormerais, Yann, et al.
Publicado: (2019)

Simple But Efficacious Enrichment of Integral Membrane Proteins and Their Interactions for In-Depth Membrane Proteomics
por: Kongpracha, Pornparn, et al.
Publicado: (2022)

Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2
por: Kato, Takafumi, et al.
Publicado: (2022)

JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells
por: Choi, Dae Woo, et al.
Publicado: (2017)

Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model
por: Sato, Tatsuhiko, et al.
Publicado: (2021)

Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor
por: Rii, Junryo, et al.
Publicado: (2021)

LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

Correction: LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014)

Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma
por: Ohshima, Yasuhiro, et al.
Publicado: (2016)

Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complex
por: Weng, Liang, et al.
Publicado: (2018)

Significance of System L Amino Acid Transporter 1 (LAT-1) and 4F2 Heavy Chain (4F2hc) Expression in Human Developing Intestines
por: Ohno, Chikara, et al.
Publicado: (2009)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020)

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
por: Kaira, Kyoichi, et al.
Publicado: (2013)

Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells
por: Srisongkram, Tarapong, et al.
Publicado: (2019)

MON-470 Pharmacological Inhibition of LAT1 Suppresses Proliferation and Hormone Synthesis in Rat Pituitary Tumor GH4 Cells [cc1] Synthesis May Be Better as Only mRNAs Were Measured
por: Sato, Motoyasu, et al.
Publicado: (2019)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

Ca(2+)-mediated higher-order assembly of heterodimers in amino acid transport system b(0,+) biogenesis and cystinuria
por: Lee, Yongchan, et al.
Publicado: (2022)

Phylogeny and taxonomy of the genus Tubakia s. lat.
por: Braun, U., et al.
Publicado: (2018)

Membrane transport proteins in melanosomes: Regulation of ions for pigmentation
por: Wiriyasermkul, Pattama, et al.
Publicado: (2020)

A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy
por: Jimbo, Keisuke, et al.
Publicado: (2020)

Correction: A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy
por: Jimbo, Keisuke, et al.
Publicado: (2021)

Dysfunctional LAT2 Amino Acid Transporter Is Associated With Cataract in Mouse and Humans
por: Knöpfel, Emilia Boiadjieva, et al.
Publicado: (2019)

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
por: Häfliger, Pascal, et al.
Publicado: (2019)

The L-type Amino Acid Transporter (LAT1) Expression in Patients with Scoliosis
por: Demura, Satoru, et al.
Publicado: (2021)

Targeted alpha therapy using astatine ((211)At)-labeled phenylalanine: A preclinical study in glioma bearing mice
por: Watabe, Tadashi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_flg6thtqvih5re74lun33ib03j